Concourse Financial Group Securities, Inc. Novo Cure LTD Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$17.82 - $30.19 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$14.54 - $33.41 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$15.61 - $23.34 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$11.83 - $24.05 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	SELL	$12.42 - $17.29 $86 - $121	-7 Closed	0 $0
Q4 2023 Feb 07, 2024	BUY	$11.13 - $15.78 $66 - $94	6 Added 600.0%	7 $0
Q3 2023 Oct 25, 2023	SELL	$16.15 - $42.35 $1,195 - $3,133	-74 Reduced 98.67%	1 $0
Q4 2022 Jan 30, 2023	BUY	$63.98 - $85.37 $4,798 - $6,402	75 New	75 $0
Q3 2022 Nov 15, 2022	SELL	$67.99 - $89.57 $8,498 - $11,196	-125 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $19,308 - $27,130	-321 Reduced 71.97%	125 $10,000
Q4 2021 Feb 07, 2022	BUY	$75.08 - $121.99 $300 - $487	4 Added 0.9%	446 $33,000
Q3 2021 Nov 09, 2021	BUY	$116.17 - $194.55 $27,067 - $45,330	233 Added 111.48%	442 $51,000
Q4 2020 Feb 02, 2021	SELL	$112.16 - $174.14 $2,018 - $3,134	-18 Reduced 7.93%	209 $36,000
Q1 2020 May 13, 2020	BUY	$57.05 - $95.75 $285 - $478	5 Added 2.25%	227 $15,000
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $887 - $1,219	13 Added 6.22%	222 $19,000
Q3 2019 Nov 13, 2019	BUY	$61.86 - $97.8 $7,979 - $12,616	129 Added 161.25%	209 $16,000
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $3,377 - $5,058	80 New	80 $5,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $0 - $0	0 New	0 $0

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

Black Rock Inc. New York, NY

12.1M
Shares

$217 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$202 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

8.95M
Shares

$160 Million
0.03% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

5.52M
Shares

$98.9 Million
8.14% of portfolio
Capital World Investors Los Angeles, CA

5.22M
Shares

$93.4 Million
0.02% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account